Feb 15 |
Omeros Corp: Continues To Offer Great Trading Opportunities
|
Feb 14 |
Omeros: Still Worth A Look Despite Narsoplimab Woes
|
Feb 7 |
3 Sleeper Stocks Under $15 Ready to Explode by 2029
|
Feb 1 |
Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
|
Jan 22 |
Institutions profited after Omeros Corporation's (NASDAQ:OMER) market cap rose US$23m last week but individual investors profited the most
|
Jan 10 |
Brian's Big Idea on Biotech
|
Nov 27 |
Omeros: Why It Is Worthwhile To Bet On Narsoplimab
|
Nov 21 |
Insiders Buying Taysha Gene Therapies And 3 Other Stocks Under $2
|
Nov 11 |
Omeros Corporation (NASDAQ:OMER) Q3 2023 Earnings Call Transcript
|
Nov 10 |
Omeros Corporation (OMER) Q3 2023 Earnings Call Transcript
|